Yes. The only information I found on earlier testing was the following
The potential therapeutic was studied thoroughly and showed safety and efficacy in preclinical and IND-enabling studies.
https://www.cureraredisease.org/blog-posts/faq-on-the-findings-from-the-crd-tmh-001-case-report
Ann: PYC Therapeutics Investor Call - 18 August 2022, page-25
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $839.8M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.5¢ | 17.5¢ | $681.3K | 3.798M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 332130 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 469568 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |